Acellular Preparation Of Polynucleotide Patents (Class 435/91.5)
-
Patent number: 8765419Abstract: The present technology relates to methods and systems for detection of pyrophosphate. As such, disclosed herein are methods and systems that permit improved pyrophosphate detection. Also disclosed herein are methods and systems which utilize improved pyrophosphate detection for nucleotide sequencing.Type: GrantFiled: April 29, 2013Date of Patent: July 1, 2014Assignee: Illumina, Inc.Inventors: Bernard Hirschbein, Filiz Gorpe-Yasar
-
Patent number: 8753846Abstract: A method of double crossover homologous recombination in a host cell comprising: a first homologous recombination event between a donor DNA molecule comprising a first element of a selectable allele and an acceptor DNA molecule comprising a second element of the selectable allele in the host cell, thereby to form a product of the first homologous recombination event in the host cell; and a second homologous recombination event within the product of the first homologous recombination event, thereby to form a product of the second homologous recombination event in the host cell which confers a selectable phenotype on the host cell, wherein the selectable phenotype arises following and in dependency on the formation of a selectable allele from the first and second elements of the selectable allele.Type: GrantFiled: February 13, 2009Date of Patent: June 17, 2014Assignee: The University of NottinghamInventors: John Timothy Heap, Nigel Peter Minton
-
Patent number: 8753847Abstract: Compositions and methods are provided for selection and enrichment of a target gene from a library of polynucleotide sequences such as might be formed from a genome or by random mutagenesis of a genetic sequence. The selection and enrichment occurs in aqueous droplets formed in an emulsion that compartmentalize individual polynucleotides from the library or a plurality of polynucleotides that may include polynucleotides not derived from the library, transcription and translation reagents and optionally additional chemical and enzyme reagents. The selection and enrichment method utilizes a polynucleotide adaptor which when ligated to the polynucleotide fragment enables amplification to occur in the presence of an adaptor specific primer.Type: GrantFiled: August 13, 2013Date of Patent: June 17, 2014Assignee: New England Biolabs, Inc.Inventors: Yu Zheng, Richard J. Roberts
-
Publication number: 20140154737Abstract: The invention provides a cross-linked poly-?-lysine polymer. The poly-?-lysine and cross linker are linked by amide bonds and may the cross linker has at least two functional groups capable of reacting with an alpha carbon amine of poly-?-lysine. The polymer is suitably insoluble in water and other solvents and is provided in particulate form. The invention provides a particulate support comprising the cross-linked poly-?-lysine polymer and the polymer may provide the particle itself or be coated on a particle for example silica. The polymer is useful in a wide range of applications including wound treatment, as a medical diagnostic comprising a particulate support and a functional material bound or retained by the support and solid phase synthesis of peptides, oligonucleotides, oligosaccharides, immobilisation of species, cell culturing and in chromatographic separation.Type: ApplicationFiled: April 20, 2012Publication date: June 5, 2014Applicant: SPHERITECH LTDInventor: Donald Wellings
-
Publication number: 20140147840Abstract: Methods of labeling and detecting a target nucleic acid by incubating a target nucleic acid with a terminal transferase to extend a terminus of the target nucleic acid and provide an extended region; hybridizing the extended region of the target nucleic acid with a template polynucleotide having a nucleotide sequence complementary to the extended region to obtain a hybridization product; and incubating the hybridization product with a nucleic acid polymerase and either a deoxynucleotide triphosphate (dNTP) having a detectable label or nucleotide triphosphate (NTP) having a detectable label to further extend the extended target nucleic acid.Type: ApplicationFiled: May 29, 2013Publication date: May 29, 2014Inventors: Sea-hee KIM, Joo-won RHEE, Ko-bong CHOI
-
Publication number: 20140148589Abstract: Aspects herein relate to composition, and related methods, for isolating and assembling DNA molecules without intermediate cloning steps.Type: ApplicationFiled: September 23, 2011Publication date: May 29, 2014Inventors: Jonathan William Babb, Shuo Cory Li, Thomas Knight, Ron Weiss
-
Patent number: 8735064Abstract: The invention relates to the control of gene expression. Specifically, the invention provides compositions and methods for the production and use of recombinant nucleic acid molecules that have the ability to specifically downregulate an expressed target gene in vivo. In some aspects, the invention provides methods for producing a hairpin DNA molecule where part of the molecule is derived from an mRNA that is a target for a small interfering RNA (siRNA) derived from the hairpin. In other aspects, the invention provides synthetic hairpin adapter oligonucleotides that are used in the construction of siRNA-producing cassettes. In other aspects, the invention provides methods for testing for the presence or absence of specific inhibitory activity of an RNAi trigger molecule, and in still other aspects, the invention provides methods for identifying an active RNAi trigger molecule from a library of RNAi trigger molecules.Type: GrantFiled: December 23, 2008Date of Patent: May 27, 2014Assignee: Bergenbio ASInventors: David Micklem, James Lorens
-
Patent number: 8728767Abstract: Methods and kits for synthesizing a plurality of oligonucleotides are provided. Methods for providing a plurality of oligonucleotides enriched for full length oligonucleotides are provided. Truncated oligonucleotides are preferentially removed from the sample by digestion. Methods are also provided for amplification of a plurality of oligonucleotides.Type: GrantFiled: December 21, 2007Date of Patent: May 20, 2014Assignee: Affymetrix, Inc.Inventor: Michael Shapero
-
Publication number: 20140127678Abstract: Methods, compositions and kits for selectively altering and detecting modified cytosine residues are provided.Type: ApplicationFiled: March 14, 2013Publication date: May 8, 2014Inventors: Shengxi Guan, Nan Dai, Zhenyu Zhu, Ivan R. Correa, Jr., Aine Quimby, Janine Borgaro
-
Patent number: 8715968Abstract: The invention features ABC1 nucleic acids and polypeptides for the diagnosis and treatment of abnormal cholesterol regulation. The invention also features methods for identifying compounds for modulating cholesterol levels in an animal (e.g., a human).Type: GrantFiled: December 23, 2003Date of Patent: May 6, 2014Assignee: Xenon Pharmaceuticals Inc.Inventors: Michael R. Hayden, Angela R. Brooks-Wiison, Simon N. Pimstone
-
Publication number: 20140113332Abstract: Provided are methods of producing a product nucleic acid. The methods include combining a template deoxyribonucleic acid (DNA), a polymerase, a template switch oligonucleotide, and dNTPs into a reaction mixture. The components are combined into the reaction mixture under conditions sufficient to produce a product nucleic acid that includes the template DNA and the template switch oligonucleotide each hybridized to adjacent regions of a single product nucleic acid that includes a region polymerized from the dNTPs by the polymerase. Aspects of the invention further include compositions and kits.Type: ApplicationFiled: October 18, 2013Publication date: April 24, 2014Inventors: Craig Betts, Andrew Alan Farmer
-
Publication number: 20140113282Abstract: Nucleosides and nucleotides are disclosed that are linked to detectable labels via a cleavable linker group.Type: ApplicationFiled: December 2, 2013Publication date: April 24, 2014Applicant: ILLUMINA CAMBRIDGE LIMITEDInventors: SHANKAR BALASUBRAMANIAN, COLIN BARNES, XIAOHAI LIU
-
Publication number: 20140113291Abstract: Four novel sequences of type B DNA polymerases and variants and analogues thereof useful for applications involving DNA polymerization in high salt conditions.Type: ApplicationFiled: June 10, 2012Publication date: April 24, 2014Inventors: David L Bernick, Andrew Holmes, Jeffrey M. Nivala
-
Publication number: 20140104753Abstract: Provided is a method of preparing a porous metal material. The method includes: obtaining a composite of a DNA hydrogel and a metal precursor by mixing the DNA hydrogel and the metal precursor; and reducing the composite of the DNA hydrogel and the metal precursor.Type: ApplicationFiled: October 16, 2013Publication date: April 17, 2014Applicant: Samsung Electronics Co., Ltd.Inventors: No-kyoung PARK, Jae-hyun HUR, Kyu-hyun IM
-
Publication number: 20140094375Abstract: Provided are compositions comprising recombinant DNA polymerases that include amino acid substitutions, insertions, deletions, and/or exogenous features that confer modified properties upon the polymerase for enhanced single molecule sequencing or nucleic acid amplification. Such properties include enhanced performance with large nucleotide analogs, increased stability, increased readlength, and improved detection of modified bases, and can also include resistance to photodamage, enhanced metal ion coordination, reduced exonuclease activity, reduced reaction rates at one or more steps of the polymerase kinetic cycle, decreased branching fraction, altered cofactor selectivity, increased yield, increased accuracy, altered speed, increased cosolvent resistance, and the like. Also provided are nucleic acids which encode the polymerases with the aforementioned phenotypes, as well as methods of using such polymerases to make a DNA or to sequence a DNA template.Type: ApplicationFiled: September 30, 2013Publication date: April 3, 2014Applicant: Pacific BioSciences of California, Inc.Inventors: Satwik Kamtekar, Erik Miller
-
Publication number: 20140093916Abstract: The present invention provides a simple and rapid method for preparing purified transposase complexes that are highly suited for fragmenting DNA. The method includes forming transposase complexes with oligonucleotide adapters in cell lysate, then purifying the complexes from the other substance in the cell lysate. Purification is accomplished using a specific binding pair, in which one member of the pair is bound to an oligonucleotide adapter of the complex and the other member of the pair is bound to a solid substrate. The bound complexes can be immediately used in DNA fragmentation reactions to produce solid substrate-bound DNA fragments, which can be used for any number of purposes, including as templates for amplification and sequencing.Type: ApplicationFiled: August 7, 2013Publication date: April 3, 2014Applicant: AGILENT TECHNOLOGIES, INC.Inventor: Alexander S. BELYAEV
-
Publication number: 20140051072Abstract: The present invention provides a method for identifying a thermostable polymerase having altered fidelity. The method consists of generating a random population of polymerase mutants by mutating at least one amino acid residue of a thermostable polymerase and screening the population for one or more active polymerase mutants by genetic selection. For example, the invention provides a method for identifying a thermostable polymerase having altered fidelity by mutating at least one amino acid residue in an active site O-helix of a thermostable polymerase. The invention also provides thermostable polymerases and nucleic acids encoding thermostable polymerases having altered fidelity, for example, high fidelity polymerases and low fidelity polymerases. The invention additionally provides a method for identifying one or more mutations in a gene by amplifying the gene with a high fidelity polymerase.Type: ApplicationFiled: March 12, 2013Publication date: February 20, 2014Applicant: University of Washington Through its Center for CommercializationInventors: Lawrence A. Loeb, Leroy Hood, Mitoshi Suzuki
-
Publication number: 20140053287Abstract: This invention relates to polypeptides having aldolase activity, including pyruvate activity such as, without limitation, HMG and/or KHG aldolase activity, polynucleotides encoding these polypeptides, and methods of making and using these polynucleotides and polypeptides. In some embodiments, the invention is directed to polypeptides having aldolase activity, including pyruvate activity such as, without limitation, HMG and/or KHG aldolase activity, including thermostable and thermotolerant activity, and polynucleotides encoding these enzymes, and making and using these polynucleotides and polypeptides. The polypeptides in accordance with the invention can be used in a variety of pharmaceutical, agricultural and industrial contexts.Type: ApplicationFiled: August 14, 2013Publication date: February 20, 2014Applicant: VERENIUM CORPORATIONInventors: David P. WEINER, Lishan ZHAO, Peter LUGINBUHL, Ellen BURKE, Toby H. RICHARDSON, Paula M. HICKS
-
Publication number: 20140045221Abstract: One embodiment of the present invention provides for a method for amplifying a template of nucleic acid target sequence contained in a sample. The method includes contacting the sample with an amplification reaction mixture containing a primer complementary to the template of nucleic acid target sequence. A temperature of the reaction is oscillated between an upper temperature and a lower temperature wherein the change in temperature is no greater than about 20° C. during a plurality of temperature cycles. The template of nucleic acid target sequence is amplified.Type: ApplicationFiled: April 20, 2012Publication date: February 13, 2014Applicant: MESA TECH INTERNATIONAL, INC.Inventors: Hong Cai, Nathan J. Cobb
-
Publication number: 20140038187Abstract: The invention provides novel nucleic acid polymerases from strains GK24 and RQ-1 of Thermus thermophilus, and nucleic acids encoding those polymerases, as well as methods for using the polymerases and nucleic acids.Type: ApplicationFiled: February 19, 2013Publication date: February 6, 2014Inventors: James ROZZELLE, Elena Bolchakova
-
Publication number: 20140038185Abstract: The present invention provides a novel technology that involves improved primer design. These primer pairs have a wide range of applications and provide high sensitivity and specificity.Type: ApplicationFiled: February 14, 2012Publication date: February 6, 2014Applicant: Swift Biosciences, Inc.Inventors: Vladimir Makarov, Sergey V. Chupreta
-
Publication number: 20140031261Abstract: Transposomes and oligonucleotide replacement methods to make DNA libraries that have distinct 5? and 3? tags, and to make directional libraries that are enriched for a desired strand.Type: ApplicationFiled: January 30, 2012Publication date: January 30, 2014Applicant: Illumina, IncInventors: Igor Y. Goryshin, Bradley Baas, Ramesh Vaidyanathan, Mark Maffitt
-
Publication number: 20130337451Abstract: The invention provides a method for obtaining DNA after bisulfite reaction which can be stored with libraries in genome reserved and has excellent storage stability, and a method for detecting methylated cytosine. Specifically, the invention provides a method for obtaining DNA complementary to single-stranded DNA in which non-methylated cytosine has been uracilated by subjecting single-stranded DNA to a bisulfite reaction and then a reverse transcriptase reaction. The resulting complementary DNA can be amplified by a PCR reaction. Methylated cytosine can be detected in single-stranded DNA by subjecting the single-stranded DNA, in order, to a bisulfite reaction, a reverse transcriptase reaction, and a PCR reaction, and then subjecting the obtained PCR amplification product to nucleotide sequence analysis.Type: ApplicationFiled: December 14, 2011Publication date: December 19, 2013Applicant: WAKO PURE CHEMICAL INDUSTRIES, LTD.Inventor: Yukinobu Hayashida
-
Patent number: 8609374Abstract: Methods are disclosed for assembling a plurality of double-stranded DNA fragments into DNA molecules in a single in vitro recombination reaction comprising contacting the plurality of double-stranded DNA fragments with a bacterial extract derived from a RecA deficient bacterial strain so as to assemble the plurality of DNA fragments into DNA molecules.Type: GrantFiled: June 19, 2012Date of Patent: December 17, 2013Assignee: Albert Einstein College of Medicine of Yeshiva UniversityInventors: Winfried Edelmann, Yongwei Zhang
-
Patent number: 8603745Abstract: Disclosed are artificial compositions that can be used as positive controls in a genetic testing assay, such as a diagnostic assay for a particular genetic disease. Such controls can be used to confirm the presence or absence of a particular mutation. Also provided are methods of generating such compositions, and methods of their use.Type: GrantFiled: March 11, 2005Date of Patent: December 10, 2013Assignees: The United States of America as represented by the Secretary of the Department of Health and Human Services, Center for Disease Control and Prevention, The Regents of the University of CaliforniaInventors: Wayne W. Grody, Michael R. Jarvis, Ramaswamy K. Iyer, Laurina O. Williams
-
Publication number: 20130323722Abstract: In a method for generating a long nucleic acid molecule, nucleic acids immobilized on a surface and having overlapping complementary sequences is released into solution. The overlapping complementary sequences are hybridized to form hybridized nucleic acids, followed by extension or ligation of the hybridized nucleic acids to synthesize the long nucleic acid molecule. The nucleic acids may comprise first and second series of nucleic acids having redundant overlapping sequences, wherein nucleic acids from the first and second series are complementary to each other. The complementary nucleic acids are hybridized to form the hybridized nucleic acids. The generated long nucleic acid molecule may have a predetermined sequence element, and it may be introduced into a system wherein the predetermined sequence element is required for replication, such that replication of the synthesized long nucleic acid molecule is indicative of the presence of the predetermined sequence element in the long nucleic acid molecule.Type: ApplicationFiled: August 13, 2013Publication date: December 5, 2013Applicant: MASSACHUSETTS INSTITUTE OF TECHNOLOGYInventors: Peter A. Carr, Brian Y. Chow, Joseph M. Jacobson, David W. Mosley, Christopher Emig
-
Publication number: 20130323797Abstract: The present invention provides compositions, methods, and kits for covalently linking nucleic acid molecules. The methods include a strand invasion step, and the compositions and kits are useful for performing such methods. For example, a method of covalently linking double stranded (ds) nucleic acid molecules can include contacting a first ds nucleic acid molecule, which has a topoisomerase linked to a 3? terminus of one end and has a single stranded 5? overhang at the same end, with a second ds nucleic acid molecule having a blunt end, such that the 5? overhang can hybridize to a complementary sequence of the blunt end of the second nucleic acid molecule, and the topoisomerase can covalently link the ds nucleic acid molecules. The methods are simpler and more efficient than previous methods for covalently linking nucleic acid sequences, and the compositions and kits facilitate practicing the methods, including methods of directionally linking two or more ds nucleic acid molecules.Type: ApplicationFiled: April 15, 2013Publication date: December 5, 2013Applicant: LIFE TECHNOLOGIES CORORATIONInventors: Jonathan CHESNUT, Steward Shuman, Knut Madden, John Heyman, Bennett Robert
-
Publication number: 20130323796Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination .sites and/or multiple topoisomerase recognition sites. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a .number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different.Type: ApplicationFiled: May 13, 2013Publication date: December 5, 2013Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Jonathan CHESNUT, John Carrino, Louis Leong, Knut Madden, Martin Gleeson, James Fan, Michael Brasch, David Cheo, James Hartley, Devon Byrd, Gary Temple
-
Publication number: 20130309725Abstract: Disclosed are compositions, methods and devices for the in situ synthesis of nucleic acids. In an exemplary embodiment, a support-bound oligonucleotide is elongated by addition of one or more nucleotides by hybridization of a partially double-stranded oligonucleotide, ligation and removal of unwanted nucleotides.Type: ApplicationFiled: May 26, 2011Publication date: November 21, 2013Applicant: GEN9, INC.Inventors: Joseph Jacobson, Senthil Ramu, Daniel Schindler
-
Publication number: 20130298265Abstract: The present invention relates to methods of assembling a plurality of genetic units to form synthetic genetic constructs. This method involves appending universal adapter oligonucleotides and flexible adapter oligonucleotides to the 5? and 3? ends of separate genetic units to be assembled to form separate dual extended genetic units. The dual extended genetic units are assembled together via homologous recombination between the flexible adapter oligonucleotide portions of the dual extended units to form synthetic genetic constructs. The present invention further relates to synthetic genetic constructs formed using the methods of the present invention, and vectors, cells, and organisms containing such synthetic genetic constructs.Type: ApplicationFiled: October 12, 2011Publication date: November 7, 2013Applicant: CORNELL UNIVERSITYInventors: Sébastien Cunnac, Alan Collmer
-
Publication number: 20130273610Abstract: A method of manufacturing a nanoparticle chain is disclosed. The method comprises the steps of: providing a single-stranded circular primer with a determined length, and amplifying the single-stranded circular primer into single-stranded DNA nanotemplate by an isothermal nucleotide amplification reaction such that an end of the single-stranded DNA nanotemplate is fixed to a surface of a substrate; and adding a single-stranded DNA probe conjugated with nanoparticle at one end of which, and attaching the single-stranded DNA probe to the corresponding sequence on the single-stranded DNA nanotemplate to form a nanoparticles chain. The method of manufacturing a nanoparticle chain further comprises providing a fluid, and the flowing direction of the fluid controls the aligning direction of the nanoparticle chain. Wherein, the inter-nanoparticle distance of the nanoparticle chain can be adjusted by adjusting a reaction temperature or adding the single-stranded DNA probe without conjugating with nanoparticles.Type: ApplicationFiled: June 5, 2012Publication date: October 17, 2013Applicant: NATIONAL APPLIED RESEARCH LABORATORIESInventors: Yen-Pei Lu, Ming-Yu Lin, Yu-Sheng Lai, Yuh-Shyong Yang, Hsuen-Li Chen, Yu-Cheng Ou
-
Publication number: 20130273526Abstract: The present invention relates to mutant DNA polymerases that exhibit reduced discrimination against labeled nucleotides into polynucleotides. The DNA polymerases of the invention have at least one mutation in the nucleotide label interaction region of the enzyme such the mutation results in reduced discrimination against labeled nucleotides. The nucleotide label interaction regions are located at portions of the O-helix, the K-helix, and the inter O-P helical loop of Taq DNA polymerase or analogous positions in other DNA polymerases. The invention also provides polynucleotides encoding the mutant DNA polymerases, optionally including expression vectors for mutant polymerase recombinant production, and further optionally including host cells containing the polynucleotides. Numerous methods of using the subject DNA polymerases are provided, including uses for chain termination sequencing and PCR.Type: ApplicationFiled: May 16, 2012Publication date: October 17, 2013Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: JOHN BRANDIS, CURTIS BLOOM, JOHN RICHARDS
-
Patent number: 8551734Abstract: Compositions and methods are provided for selection and enrichment of a target gene from a library of polynucleotide sequences such as might be formed from a genome or by random mutagenesis of a genetic sequence. The selection and enrichment occurs in aqueous droplets formed in an emulsion that compartmentalize individual polynucleotides from the library or a plurality of polynucleotides that may include polynucleotides not derived from the library, transcription and translation reagents and optionally additional chemical and enzyme reagents. The selection and enrichment method utilizes a polynucleotide adaptor which when ligated to the polynucleotide fragment enables amplification to occur in the presence of an adaptor specific primer.Type: GrantFiled: March 8, 2012Date of Patent: October 8, 2013Inventors: Yu Zheng, Richard J. Roberts
-
Publication number: 20130261014Abstract: 3-alkynyl inosine analogs and their uses as universal bases are provided. The inosine analogues can be incorporated into nucleic acid primers and probes. They do not significantly destabilize nucleic acid duplexes. As a result, the novel nucleic acid primers and probes incorporating the inosine analogues can be used in a variety of methods. The analogs function unexpectedly well as universal bases. Not only do they stabilize duplexes substantially more than hypoxanthine opposite A, C, T, and G but they are also recognized in primers by polymerases, allowing efficient amplification.Type: ApplicationFiled: March 14, 2013Publication date: October 3, 2013Inventors: Alexei Vorobiev, Eugeny A. Lukhtanov, Noah Scarr
-
Patent number: 8541003Abstract: SARS (severe acute respiratory syndrome virus, a coronavirus) immunogens, antigens, or epitopes, nucleic acid molecules encoding such immunogens, antigens, or epitopes; vectors containing such nucleic acid molecules, e.g., viral vectors such as baculovirus vectors, DNA vectors, such as DNA plasmid vectors, e.g., DNA plasmids that express a nucleic acid molecule in a mammalian cell, uses for such immunogens, antigens or epitopes and vectors, e.g., as an active component immunogenic, immunological or vaccine compositions, or to generate antibodies, such as monoclonal antibodies, and methods for making, and using such immunogens, antigens or epitopes, vectors, antibodies, including in methods for eliciting an immunological or immunogenic or vaccine response, as well as in assays or diagnostic kits or methods, are discussed, as well as a seamless fusion of sequences in a plasmid or vector, e.g., a sequence encoding a leader sequence and a sequence encoding a protein, epitope or immunogen or antigen.Type: GrantFiled: June 21, 2004Date of Patent: September 24, 2013Assignee: Protein Sciences CorporationInventors: D. Karl Anderson, Kathleen M. Holtz-Corris, Rick Chubet, Daniel Adams, Manon Cox
-
Publication number: 20130244888Abstract: The invention provides nucleoside and nucleotide molecules containing cleavable linkers linking a label such as a dye. The invention also provides nucleosides and nucleotide molecules containing a blocking group, either removable or non-removable. The invention additionally provides methods of using the nucleoside and nucleotide molecules containing a cleavable linker and/or a blocking group.Type: ApplicationFiled: March 18, 2013Publication date: September 19, 2013Applicant: ILLUMINA, INC.Inventors: Chanfeng Zhao, Igor Kozlov, Melissa Won
-
Publication number: 20130224736Abstract: A microfluidic device and method for enzymatic processing of ultra-long macromolecules is accomplished using a microfluidic device a reaction chamber with a first manifold, a second manifold, and a plurality of reaction channels. Each reaction channel extends from the first manifold to the second manifold. First inlet and outlet channels fill the reaction channels via the manifolds with one or more macromolecule containers suspended in a first carrier fluid. The first inlet and outlet channels are configured such that a flow is guided through the reaction channels, and an enzymatic reagent is fed to the reaction chamber essentially without displacing the macromolecule containers trapped in the reaction channels. The second set of inlets and outlets are configured such that a flow established from the second inlet to the second outlet is guided through at least one of the manifolds and bypasses the reaction channels.Type: ApplicationFiled: October 24, 2011Publication date: August 29, 2013Inventors: Rodolphe Marie, Anders Kristensen, Kristian Hagsted Rasmussen, Kalim Ullah Mir
-
Publication number: 20130217007Abstract: Provided are compositions comprising recombinant DNA polymerases that include amino acid substitutions, insertions, deletions, and/or exogenous features that confer modified properties upon the polymerase for enhanced single molecule sequencing. Such properties include increased resistance to photodamage, and can also include enhanced metal ion coordination, reduced exonuclease activity, reduced reaction rates at one or more steps of the polymerase kinetic cycle, decreased branching fraction, altered cofactor selectivity, increased yield, increased thermostability, increased accuracy, increased speed, increased readlength, and the like. Also provided are nucleic acids which encode the polymerases with the aforementioned phenotypes, as well as methods of using such polymerases to make a DNA or to sequence a DNA template.Type: ApplicationFiled: January 31, 2013Publication date: August 22, 2013Applicant: Pacific Biosciences of California, Inc.Inventor: Pacific Biosciences of California, Inc.
-
Publication number: 20130189743Abstract: Nucleosides and nucleotides are disclosed that are linked to detectable labels via a cleavable linker group.Type: ApplicationFiled: March 8, 2013Publication date: July 25, 2013Applicant: Illumina Cambridge LimitedInventors: Shankar BALASUBRAMANIAN, Colin Barnes, Xiaohai Liu, John Milton
-
Publication number: 20130183718Abstract: The present invention relates to a method of RNA synthesis by RNA-dependent RNA polymerases (RdRp) displaying an RNA polymerase activity on single-stranded DNA templates and to a kit for carrying out the method. The RdRp showing DNA-dependent RNA polymerase activity has a “right hand conformation” and the amino acid sequence of said RdRp comprises a conserved arrangement of the following sequence motifs: a. XXDYS, b. GXPSG, c. YGDD, d. XXYGL, e. XXXXFLXRXX (with the following meanings: D: aspartate, Y: tyrosine, S: serine, G: glycine, P: proline, L: leucine, F: phenylalanine, R: arginine, X: any amino acid). This class of RdRp is exemplified by the RdRp enzymes of viruses of the Caliciviridae family. The present invention also relates to a method for transferring at least one ribonucleotide (rC, rA, rU or rG) to the 3?-end of a single-stranded DNA by using the RdRp of the invention.Type: ApplicationFiled: September 20, 2011Publication date: July 18, 2013Applicant: RibpxX GmbHInventor: Jacques Rohayem
-
Patent number: 8486665Abstract: A heat labile alkaline phosphatase enzyme and methods of using the same and kits including the same are disclosed. Specifically, a nucleotide sequence of, peptide sequence of, methods of using, and kits comprising, a heat labile alkaline phosphatase isolated from Colwellia psychrerythraea are provided. Methods of over-expression and purification of the recombinant alkaline phosphatase and mutants thereof are also disclosed. Methods of over-expressing and purifying commercially useful quantities of active recombinant heat labile alkaline phosphatase fusion enzymes from C. psychrerythraea, wherein the fusion enzymes comprise one or more heterologous leader sequences are disclosed. The disclosed C. psychrerythraea heat labile alkaline phosphatase has properties similar to shrimp alkaline phosphatase and can be substituted for shrimp alkaline phosphatase in assays involving the same.Type: GrantFiled: January 23, 2012Date of Patent: July 16, 2013Assignee: Affymetrix, Inc.Inventors: Jeannine C. Muller-Greven, Marc A. Post, Christopher J. Kubu
-
Publication number: 20130171631Abstract: The invention relates to a novel method for enzymatically marking nucleic acid chains (target sequences) by using nucleotide conjugates. Said nucleotide conjugates are capable of binding specifically to the target sequence under reaction conditions and of being incorporated in the complementary growing strand by means of a polymerase. The nucleic acid chains marked with such conjugates can be bound to the solid phase. The marking can be carried out in parallel with the enzymatic amplification of target sequences.Type: ApplicationFiled: October 26, 2010Publication date: July 4, 2013Inventors: Claus Becker, Dmitry Cherkasov
-
Publication number: 20130157870Abstract: The invention generally relates to methods for obtaining a sequence, such as a consensus sequence or a haplotype sequence. In certain embodiments, methods of the invention involve determining an amount of amplifiable nucleic acid present in a sample, partitioning the nucleic acid based upon results of the determining step such that each partitioned portion includes, on average, a subset of unique sequences, sequencing the nucleic acid to obtain sequence reads, and assembling a consensus sequence from the reads.Type: ApplicationFiled: September 10, 2012Publication date: June 20, 2013Applicant: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYInventors: Dmitry Pushkarev, Stephen R. Quake, Ayelet Voskoboynik, Michael Kertesz
-
Publication number: 20130149749Abstract: An engineered DNA polymerase characterised in that the polymerase exhibits an enhanced ability to process nucleic acid in the presence of environmental and biological inhibitors compared to wild type DNA polymerase.Type: ApplicationFiled: February 18, 2013Publication date: June 13, 2013Applicant: Medical Research CouncilInventor: Medical Research Council
-
Publication number: 20130149747Abstract: Disclosed are DNA polymerases having increased reverse transcriptase efficiency relative to a corresponding, unmodified polymerase. The polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the DNA polymerases.Type: ApplicationFiled: December 5, 2012Publication date: June 13, 2013Applicant: Roche Molecular Systems, Inc.Inventor: Roche Molecular Systems, Inc.
-
Publication number: 20130149748Abstract: Disclosed are DNA polymerases having increased reverse transcriptase efficiency relative to a corresponding, unmodified polymerase. The polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the DNA polymerases.Type: ApplicationFiled: December 5, 2012Publication date: June 13, 2013Applicant: Roche Molecular Systems, Inc.Inventor: Roche Molecular Systems, Inc.
-
Publication number: 20130130320Abstract: The invention relates to a nucleic acid polymerase capable of producing a non-DNA nucleotide polymer from a DNA nucleotide polymer template, said polymerase comprising amino acid sequence having at least 36% identity to the amino acid sequence of SEQ ID NO:1, wherein said amino acid sequence is mutated relative to the amino acid sequence of SEQ ID NO:1 at one or more residues of the thumb region, said residues selected from: amino acids 651 to 679 (patch 10A); wherein said amino acid sequence is mutated relative to the amino acid sequence of SEQ ID NO:1 at residue E664. In one embodiment said polymerase comprises the mutations Y409G and E664K. In one embodiment said polymerase comprises amino acid sequence corresponding to SEQ ID NO:12.Type: ApplicationFiled: April 14, 2011Publication date: May 23, 2013Inventors: Philipp Holliger, Christopher Cozens, Vitor B. Pinheiro
-
Publication number: 20130130249Abstract: A method for producing a nucleic acid molecule from a template nucleic acid sequence and a linking unit attached to a primer, which method comprises a step of contacting the template nucleic acid sequence with a nucleic acid polymerase under conditions which allow the nucleic acid polymerase to produce the nucleic acid molecule from the primer based on the template nucleic acid sequence, wherein the linking unit is attached to a target site in the template nucleic acid sequence with a covalent linkage.Type: ApplicationFiled: November 16, 2012Publication date: May 23, 2013Applicant: Vilnius UniversityInventor: Vilnius University
-
Publication number: 20130130323Abstract: The present invention provides compositions and methods for reducing steric hindrance in the product of nucleic acid polymerase reaction. Methods and compositions of the invention encompass application of exonucleases, endonucleases, and uracil-DNA glycosylases to a nucleic acid polymerase reaction such that newly formed nucleic acid strands are modified (e.g., cleaved) while the polymerase reaction continues to proceed.Type: ApplicationFiled: May 10, 2012Publication date: May 23, 2013Applicant: Pacific Biosciences of California, Inc.Inventors: Congcong Ma, Paul Wyatt
-
Patent number: RE44596Abstract: The present invention relates to a method for the diagnosis and/or the follow up of the evolution of cancer, which includes the analysis and quantification of over expressed and amplified genes in the plasma/serum of cancer patients or persons suspected to harbor cancer. This is achieved by analyzing together the amount of DNA and RNA of certain genes in the plasma/serum of cancer patients that are the reflection of a gene amplification and/or a gene over expression in comparison to healthy controls.Type: GrantFiled: April 13, 2012Date of Patent: November 12, 2013Assignee: Guardant Health, Inc.Inventors: Maurice Stroun, Philippe Anker